Clinical Trials Browser

Meningeal Neoplasms × pertuzumab × 90 days × Clear all

NCT04588545 2026-05-26

Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease

Phase 1/2 Active not recruiting

Meningeal Neoplasms, Meningeal Carcinomatosis